Aerovate Therapeutics Inc Strategic Asset Allocation Index
Aerovate Therapeutics Inc strategic asset allocation index. Aerovate Therapeutics Inc (AVTE) has a Strategic Asset Allocation Index of 0.2% as of June 2023. Strategic assets (PP&E of $245.00K plus long-term investments of $-) total $245.00K, measured against net assets of $141.93 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Aerovate Therapeutics Inc (AVTE) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Aerovate Therapeutics Inc (2021–2021)
Strategic asset allocation index of Aerovate Therapeutics Inc from 2021 to 2021. This chart shows how Aerovate Therapeutics Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of June 2023, the index stands at 0.2%, representing strategic assets of $245.00K against net assets of $141.93 Million USD. Check Aerovate Therapeutics Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Aerovate Therapeutics Inc Strategic Asset Allocation Index by Year (2021–2021)
Aerovate Therapeutics Inc strategic asset allocation index by year from 2021 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Aerovate Therapeutics Inc from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Aerovate Therapeutics Inc (AVTE) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.4% | $728.00K | $728.00K | $- | $172.42 Million | — |